Japanese drugmaker Eisai Co Ltd and U.S. biotech firm Biogen Inc said in a joint statement that the Japanese Ministry of Health, Labour and Welfare has granted priority review status to their Alzheimer's disease treatment.
said in a joint statement that the Japanese Ministry of Health, Labour and Welfare has granted priority review status to their Alzheimer's disease treatment.
The drug, lecanemab, which was recently granted accelerated approval in the United States, is an antibody that has been shown to remove sticky deposits of a protein called amyloid beta from the brains of patients in the early stages of the mind-wasting disease. In their Jan. 29 statement, the companies said priority review in Japan is granted to new medicines recognised as having high medical utility for serious diseases. Once the priority status has been granted, the target total review period is shortened, they said.for priority status was based on results from a late-stage study in which the drug was shown to reduce the rate of cognitive decline in patients with early Alzheimer's by 27%, compared with a placebo.
of the drug with the U.S. Food and Drug Administration as a treatment for patients in the earliest stages of the neurodegenerative disease.Our Standards:
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Japan grants priority review status to Alzheimer's treatment from Eisai-BiogenJapanese drugmaker Eisai Co Ltd and Biogen Inc said on Sunday the Japanese Ministry of Health, Labour and Welfare has given priority review for their Alzheimer's disease drug.
Lire la suite »
Medical experts divided on whether 2nd FDA-approved Alzheimer's drug provides a benefitThe Food Drug and Administration recently approved a drug that may help patients in the early stages of Alzheimer's by slowing down the progression of the disease. In clinical trials, the drug called lecanemab reduced the rate of cognitive decline among participants.
Lire la suite »
Silver Alert issued for missing Harris County man with Alzheimer's diseaseIT TAKES 2 SECONDS TO SHARE: According to the Silver Alert, Clarence Toles, 70, was last seen around 7:45 a.m. Friday in Harris County.
Lire la suite »
Man with Alzheimer's disease reported missing in Palo AltoHenry Luce was last seen Saturday afternoon when he walked away from his home, according to police.
Lire la suite »
Study of 500,000 Medical Records Links Viruses to Alzheimer's Again And AgainA study of around 500,000 medical records has suggested that severe viral infections like encephalitis and pneumonia increase the risk of neurodegenerative diseases like Parkinson's and Alzheimer's.
Lire la suite »
Japan eyes easing S.Korea export controls as Seoul seeks to improve ties -mediaJapan is considering relaxing controls on exports to South Korea as its president, Yoon Suk-yeol, seeks to improve ties amid a strained East Asian security environment, the Sankei newspaper reported on Saturday.
Lire la suite »